Device Trial Radar · NCT06932055
A Phase II Pilot Study of the Trillium Full Face Mask
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jul 15, 2025
Primary completion
Aug 19, 2025
Study completion Aug 19, 2025
Sponsor
- Lead sponsor
- Philips Clinical & Medical Affairs GlobalPublic (PHG)
- Sponsor type
- Industry
- Collaborators
- Florida Lung & Sleep Associates
- First posted
- Apr 17, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This will be a single-center, open-label randomized crossover design pilot study to evaluate the clinical safety, clinical performance, and clinical benefit of the Trillium full face mask
Conditions
- Obstructive Sleep Apnea
Interventions
Trillium Full Face MaskDevice
The Trillium Full Face Mask (FFM) (Philips Respironics, Murrysville, PA) is an over-the-nose, full-face mask with the hose connection in the front. The mask is used with a positive airway pressure (PAP) therapy device and covers both the nose and mouth, ensuring pressurized air is delivered directly into the patient's airways.
AirFit F20Device
The AirFit F20 (ResMed, San Diego, California) is an externally placed vented mask covering the mouth and the nose of the patient. It provides a seal such that pressure from a positive pressure source is directed to the patient's nose and/or mouth. The mask connects via a standard conical connector to a conventional air delivery hose, which in turn connects to the positive pressure source. The mask is held in place with an adjustable headgear that straps the mask to the face. The AirFit F20 mask system comprises four subassemblies: cushion, frame, elbow and headgear. The elbow incorporates the vent array and anti-asphyxia valve safety features.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Unintentional Leak During Trillium Mask UseTime frame: During the approximately 15-day Trillium mask treatment period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Florida Lung & Sleep Associates
Lehigh Acres, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.